Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cytological Techniques | 1 | 2013 | 79 | 0.48 | Why? |
| Camelus | 1 | 2018 | 1425 | 0.39 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 6 | 2020 | 8843 | 0.31 | Why? |
| Bronchi | 1 | 2013 | 1048 | 0.30 | Why? |
| Washington | 3 | 2021 | 1722 | 0.21 | Why? |
| Student Health Services | 1 | 2021 | 69 | 0.21 | Why? |
| Epithelial Cells | 1 | 2013 | 3508 | 0.21 | Why? |
| Antibodies, Viral | 12 | 2022 | 51949 | 0.20 | Why? |
| Ribonucleosides | 1 | 2020 | 95 | 0.20 | Why? |
| Disease Transmission, Infectious | 4 | 2021 | 9044 | 0.16 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.15 | Why? |
| Defective Viruses | 1 | 2016 | 98 | 0.15 | Why? |
| Nucleocapsid Proteins | 3 | 2020 | 3120 | 0.13 | Why? |
| Bronchial Neoplasms | 1 | 2013 | 18 | 0.13 | Why? |
| Cell Polarity | 1 | 2013 | 85 | 0.12 | Why? |
| Virus Cultivation | 1 | 2016 | 579 | 0.12 | Why? |
| Viral Tropism | 1 | 2020 | 1329 | 0.12 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.11 | Why? |
| Community Health Services | 1 | 2021 | 1000 | 0.11 | Why? |
| Cell Line | 4 | 2021 | 12040 | 0.11 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.11 | Why? |
| Skilled Nursing Facilities | 1 | 2020 | 1098 | 0.11 | Why? |
| Asymptomatic Diseases | 2 | 2021 | 3444 | 0.11 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.10 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.10 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.10 | Why? |
| Zoonoses | 2 | 2018 | 3034 | 0.10 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.10 | Why? |
| Israel | 1 | 2018 | 2751 | 0.10 | Why? |
| Wisconsin | 2 | 2021 | 607 | 0.09 | Why? |
| Virus Replication | 2 | 2020 | 14331 | 0.09 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2016 | 846 | 0.09 | Why? |
| Reverse Transcription | 2 | 2022 | 673 | 0.09 | Why? |
| Cell Line, Tumor | 2 | 2016 | 3608 | 0.09 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.09 | Why? |
| SARS Virus | 4 | 2020 | 13021 | 0.09 | Why? |
| Seroepidemiologic Studies | 3 | 2019 | 10017 | 0.09 | Why? |
| Vero Cells | 3 | 2020 | 14117 | 0.08 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.08 | Why? |
| Animals | 8 | 2021 | 78931 | 0.08 | Why? |
| Sensitivity and Specificity | 7 | 2021 | 22971 | 0.08 | Why? |
| Antibodies, Monoclonal | 2 | 2021 | 8041 | 0.08 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.08 | Why? |
| Adenocarcinoma | 1 | 2013 | 651 | 0.08 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.07 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| Jordan | 2 | 2016 | 701 | 0.06 | Why? |
| Humans | 31 | 2022 | 930598 | 0.06 | Why? |
| Iowa | 1 | 2021 | 111 | 0.06 | Why? |
| Viral Structural Proteins | 1 | 2005 | 491 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.05 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.05 | Why? |
| Oregon | 1 | 2021 | 224 | 0.05 | Why? |
| Fluoresceins | 1 | 2020 | 46 | 0.05 | Why? |
| Antibody Specificity | 1 | 2005 | 1328 | 0.05 | Why? |
| Membrane Glycoproteins | 2 | 2007 | 2273 | 0.05 | Why? |
| Louisiana | 1 | 2021 | 353 | 0.05 | Why? |
| Rhode Island | 1 | 2021 | 425 | 0.05 | Why? |
| Arizona | 1 | 2021 | 416 | 0.05 | Why? |
| Utah | 1 | 2020 | 425 | 0.05 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.05 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 7868 | 0.05 | Why? |
| Half-Life | 1 | 2020 | 298 | 0.05 | Why? |
| Connecticut | 1 | 2021 | 547 | 0.05 | Why? |
| Hydroxylamines | 1 | 2020 | 182 | 0.05 | Why? |
| Primary Cell Culture | 1 | 2020 | 501 | 0.05 | Why? |
| Cytidine | 1 | 2020 | 219 | 0.04 | Why? |
| Research Personnel | 1 | 2008 | 1037 | 0.04 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2019 | 393 | 0.04 | Why? |
| Michigan | 1 | 2021 | 988 | 0.04 | Why? |
| Viral Envelope Proteins | 2 | 2007 | 3539 | 0.04 | Why? |
| Contact Tracing | 1 | 2017 | 8448 | 0.04 | Why? |
| Random Allocation | 1 | 2020 | 773 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2022 | 13720 | 0.04 | Why? |
| Antibiotic Prophylaxis | 1 | 2020 | 399 | 0.04 | Why? |
| Female | 12 | 2022 | 380317 | 0.04 | Why? |
| Mice | 3 | 2021 | 21357 | 0.04 | Why? |
| Aviation | 1 | 2017 | 77 | 0.04 | Why? |
| Massachusetts | 1 | 2021 | 1279 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| Adult | 11 | 2022 | 244371 | 0.04 | Why? |
| United Arab Emirates | 1 | 2019 | 704 | 0.04 | Why? |
| Fluorescent Dyes | 1 | 2020 | 536 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Male | 11 | 2022 | 367725 | 0.04 | Why? |
| Universities | 2 | 2021 | 4374 | 0.04 | Why? |
| DNA Primers | 1 | 2020 | 1170 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2008 | 12361 | 0.04 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.04 | Why? |
| Fomites | 1 | 2021 | 709 | 0.04 | Why? |
| Cats | 1 | 2021 | 1890 | 0.03 | Why? |
| RNA | 1 | 2021 | 1278 | 0.03 | Why? |
| Dogs | 1 | 2021 | 2529 | 0.03 | Why? |
| Family Health | 1 | 2019 | 731 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2020 | 1083 | 0.03 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.03 | Why? |
| Adolescent | 5 | 2022 | 86841 | 0.03 | Why? |
| Chiroptera | 1 | 2008 | 3530 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 6 | 2021 | 37182 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| United States | 4 | 2021 | 46150 | 0.03 | Why? |
| Cross Infection | 1 | 2014 | 8675 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.03 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Prisons | 1 | 2021 | 980 | 0.03 | Why? |
| Child | 4 | 2021 | 70012 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Bayes Theorem | 1 | 2020 | 3237 | 0.03 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.02 | Why? |
| Health Personnel | 2 | 2017 | 29646 | 0.02 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Young Adult | 4 | 2022 | 93724 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.02 | Why? |
| Middle Aged | 7 | 2022 | 270681 | 0.02 | Why? |
| Laboratories | 1 | 2021 | 2858 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Biology | 1 | 2008 | 71 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Saudi Arabia | 1 | 2017 | 4423 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Nursing Homes | 1 | 2022 | 4155 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Students | 1 | 2021 | 5255 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.01 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.01 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2020 | 10998 | 0.01 | Why? |
| Epitope Mapping | 1 | 2005 | 1240 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2021 | 9659 | 0.01 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Travel | 1 | 2017 | 7220 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Viral Matrix Proteins | 1 | 2005 | 1243 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Recombinant Proteins | 1 | 2007 | 3786 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Serologic Tests | 1 | 2007 | 4359 | 0.01 | Why? |
| Neutralization Tests | 1 | 2005 | 6698 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Risk Factors | 1 | 2019 | 71621 | 0.01 | Why? |
Harcourt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(445)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_